Global and Japan Anti-obesity Medicine Market Size, Status and Forecast 2023-2027

Report ID: 1127929 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Prescription Drugs
        1.2.3 OTC Drugs
    1.3 Market by Application
        1.3.1 Global Anti-obesity Medicine Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Men
        1.3.3 Women
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Anti-obesity Medicine Market Perspective (2016-2027)
    2.2 Anti-obesity Medicine Growth Trends by Regions
        2.2.1 Anti-obesity Medicine Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Anti-obesity Medicine Historic Market Share by Regions (2016-2021)
        2.2.3 Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027)
    2.3 Anti-obesity Medicine Industry Dynamic
        2.3.1 Anti-obesity Medicine Market Trends
        2.3.2 Anti-obesity Medicine Market Drivers
        2.3.3 Anti-obesity Medicine Market Challenges
        2.3.4 Anti-obesity Medicine Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Anti-obesity Medicine Players by Revenue
        3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2016-2021)
        3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2016-2021)
    3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue
    3.4 Global Anti-obesity Medicine Market Concentration Ratio
        3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2020
    3.5 Anti-obesity Medicine Key Players Head office and Area Served
    3.6 Key Players Anti-obesity Medicine Product Solution and Service
    3.7 Date of Enter into Anti-obesity Medicine Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-obesity Medicine Breakdown Data by Type
    4.1 Global Anti-obesity Medicine Historic Market Size by Type (2016-2021)
    4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027)

5 Anti-obesity Medicine Breakdown Data by Application
    5.1 Global Anti-obesity Medicine Historic Market Size by Application (2016-2021)
    5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Anti-obesity Medicine Market Size (2016-2027)
    6.2 North America Anti-obesity Medicine Market Size by Type
        6.2.1 North America Anti-obesity Medicine Market Size by Type (2016-2021)
        6.2.2 North America Anti-obesity Medicine Market Size by Type (2022-2027)
        6.2.3 North America Anti-obesity Medicine Market Size by Type (2016-2027)
    6.3 North America Anti-obesity Medicine Market Size by Application
        6.3.1 North America Anti-obesity Medicine Market Size by Application (2016-2021)
        6.3.2 North America Anti-obesity Medicine Market Size by Application (2022-2027)
        6.3.3 North America Anti-obesity Medicine Market Size by Application (2016-2027)
    6.4 North America Anti-obesity Medicine Market Size by Country
        6.4.1 North America Anti-obesity Medicine Market Size by Country (2016-2021)
        6.4.2 North America Anti-obesity Medicine Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Anti-obesity Medicine Market Size (2016-2027)
    7.2 Europe Anti-obesity Medicine Market Size by Type
        7.2.1 Europe Anti-obesity Medicine Market Size by Type (2016-2021)
        7.2.2 Europe Anti-obesity Medicine Market Size by Type (2022-2027)
        7.2.3 Europe Anti-obesity Medicine Market Size by Type (2016-2027)
    7.3 Europe Anti-obesity Medicine Market Size by Application
        7.3.1 Europe Anti-obesity Medicine Market Size by Application (2016-2021)
        7.3.2 Europe Anti-obesity Medicine Market Size by Application (2022-2027)
        7.3.3 Europe Anti-obesity Medicine Market Size by Application (2016-2027)
    7.4 Europe Anti-obesity Medicine Market Size by Country
        7.4.1 Europe Anti-obesity Medicine Market Size by Country (2016-2021)
        7.4.2 Europe Anti-obesity Medicine Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Anti-obesity Medicine Market Size (2016-2027)
    8.2 Asia-Pacific Anti-obesity Medicine Market Size by Type
        8.2.1 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2027)
    8.3 Asia-Pacific Anti-obesity Medicine Market Size by Application
        8.3.1 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2027)
    8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region
        8.4.1 Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Anti-obesity Medicine Market Size (2016-2027)
    9.2 Latin America Anti-obesity Medicine Market Size by Type
        9.2.1 Latin America Anti-obesity Medicine Market Size by Type (2016-2021)
        9.2.2 Latin America Anti-obesity Medicine Market Size by Type (2022-2027)
        9.2.3 Latin America Anti-obesity Medicine Market Size by Type (2016-2027)
    9.3 Latin America Anti-obesity Medicine Market Size by Application
        9.3.1 Latin America Anti-obesity Medicine Market Size by Application (2016-2021)
        9.3.2 Latin America Anti-obesity Medicine Market Size by Application (2022-2027)
        9.3.3 Latin America Anti-obesity Medicine Market Size by Application (2016-2027)
    9.4 Latin America Anti-obesity Medicine Market Size by Country
        9.4.1 Latin America Anti-obesity Medicine Market Size by Country (2016-2021)
        9.4.2 Latin America Anti-obesity Medicine Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Anti-obesity Medicine Market Size (2016-2027)
    10.2 Middle East & Africa Anti-obesity Medicine Market Size by Type
        10.2.1 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2027)
    10.3 Middle East & Africa Anti-obesity Medicine Market Size by Application
        10.3.1 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2027)
    10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country
        10.4.1 Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Alizyme
        11.1.1 Alizyme Company Details
        11.1.2 Alizyme Business Overview
        11.1.3 Alizyme Anti-obesity Medicine Introduction
        11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2016-2021)
        11.1.5 Alizyme Recent Development
    11.2 Amylin Pharmaceuticals
        11.2.1 Amylin Pharmaceuticals Company Details
        11.2.2 Amylin Pharmaceuticals Business Overview
        11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction
        11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
        11.2.5 Amylin Pharmaceuticals Recent Development
    11.3 Arena Pharmaceuticals
        11.3.1 Arena Pharmaceuticals Company Details
        11.3.2 Arena Pharmaceuticals Business Overview
        11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction
        11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
        11.3.5 Arena Pharmaceuticals Recent Development
    11.4 Boehringer Ingelheim
        11.4.1 Boehringer Ingelheim Company Details
        11.4.2 Boehringer Ingelheim Business Overview
        11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction
        11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021)
        11.4.5 Boehringer Ingelheim Recent Development
    11.5 Eisai
        11.5.1 Eisai Company Details
        11.5.2 Eisai Business Overview
        11.5.3 Eisai Anti-obesity Medicine Introduction
        11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2016-2021)
        11.5.5 Eisai Recent Development
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Details
        11.6.2 GlaxoSmithKline Business Overview
        11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction
        11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021)
        11.6.5 GlaxoSmithKline Recent Development
    11.7 Orexigen Therapeutics
        11.7.1 Orexigen Therapeutics Company Details
        11.7.2 Orexigen Therapeutics Business Overview
        11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction
        11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021)
        11.7.5 Orexigen Therapeutics Recent Development
    11.8 Vivus
        11.8.1 Vivus Company Details
        11.8.2 Vivus Business Overview
        11.8.3 Vivus Anti-obesity Medicine Introduction
        11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2016-2021)
        11.8.5 Vivus Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Anti-obesity Medicine Introduction
        11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2016-2021)
        11.9.5 Pfizer Recent Development
    11.10 Roche
        11.10.1 Roche Company Details
        11.10.2 Roche Business Overview
        11.10.3 Roche Anti-obesity Medicine Introduction
        11.10.4 Roche Revenue in Anti-obesity Medicine Business (2016-2021)
        11.10.5 Roche Recent Development
    11.11 Merck
        11.11.1 Merck Company Details
        11.11.2 Merck Business Overview
        11.11.3 Merck Anti-obesity Medicine Introduction
        11.11.4 Merck Revenue in Anti-obesity Medicine Business (2016-2021)
        11.11.5 Merck Recent Development
    11.12 Novo Nordisk
        11.12.1 Novo Nordisk Company Details
        11.12.2 Novo Nordisk Business Overview
        11.12.3 Novo Nordisk Anti-obesity Medicine Introduction
        11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021)
        11.12.5 Novo Nordisk Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Anti-obesity Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Prescription Drugs
    Table 3. Key Players of OTC Drugs
    Table 4. Global Anti-obesity Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Anti-obesity Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Anti-obesity Medicine Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Anti-obesity Medicine Market Share by Regions (2016-2021)
    Table 8. Global Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
    Table 10. Anti-obesity Medicine Market Trends
    Table 11. Anti-obesity Medicine Market Drivers
    Table 12. Anti-obesity Medicine Market Challenges
    Table 13. Anti-obesity Medicine Market Restraints
    Table 14. Global Anti-obesity Medicine Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Anti-obesity Medicine Market Share by Players (2016-2021)
    Table 16. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020)
    Table 17. Ranking of Global Top Anti-obesity Medicine Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Anti-obesity Medicine Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Anti-obesity Medicine Product Solution and Service
    Table 21. Date of Enter into Anti-obesity Medicine Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
    Table 25. Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Anti-obesity Medicine Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Anti-obesity Medicine Revenue Market Share by Application (2016-2021)
    Table 29. Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Anti-obesity Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Alizyme Company Details
    Table 62. Alizyme Business Overview
    Table 63. Alizyme Anti-obesity Medicine Product
    Table 64. Alizyme Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 65. Alizyme Recent Development
    Table 66. Amylin Pharmaceuticals Company Details
    Table 67. Amylin Pharmaceuticals Business Overview
    Table 68. Amylin Pharmaceuticals Anti-obesity Medicine Product
    Table 69. Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 70. Amylin Pharmaceuticals Recent Development
    Table 71. Arena Pharmaceuticals Company Details
    Table 72. Arena Pharmaceuticals Business Overview
    Table 73. Arena Pharmaceuticals Anti-obesity Medicine Product
    Table 74. Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 75. Arena Pharmaceuticals Recent Development
    Table 76. Boehringer Ingelheim Company Details
    Table 77. Boehringer Ingelheim Business Overview
    Table 78. Boehringer Ingelheim Anti-obesity Medicine Product
    Table 79. Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 80. Boehringer Ingelheim Recent Development
    Table 81. Eisai Company Details
    Table 82. Eisai Business Overview
    Table 83. Eisai Anti-obesity Medicine Product
    Table 84. Eisai Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 85. Eisai Recent Development
    Table 86. GlaxoSmithKline Company Details
    Table 87. GlaxoSmithKline Business Overview
    Table 88. GlaxoSmithKline Anti-obesity Medicine Product
    Table 89. GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 90. GlaxoSmithKline Recent Development
    Table 91. Orexigen Therapeutics Company Details
    Table 92. Orexigen Therapeutics Business Overview
    Table 93. Orexigen Therapeutics Anti-obesity Medicine Product
    Table 94. Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 95. Orexigen Therapeutics Recent Development
    Table 96. Vivus Company Details
    Table 97. Vivus Business Overview
    Table 98. Vivus Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 99. Vivus Recent Development
    Table 100. Pfizer Company Details
    Table 101. Pfizer Business Overview
    Table 102. Pfizer Anti-obesity Medicine Product
    Table 103. Pfizer Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 104. Pfizer Recent Development
    Table 105. Roche Company Details
    Table 106. Roche Business Overview
    Table 107. Roche Anti-obesity Medicine Product
    Table 108. Roche Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 109. Roche Recent Development
    Table 110. Merck Company Details
    Table 111. Merck Business Overview
    Table 112. Merck Anti-obesity Medicine Product
    Table 113. Merck Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 114. Merck Recent Development
    Table 115. Novo Nordisk Company Details
    Table 116. Novo Nordisk Business Overview
    Table 117. Novo Nordisk Anti-obesity Medicine Product
    Table 118. Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
    Table 119. Novo Nordisk Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-obesity Medicine Market Share by Type: 2020 VS 2027
    Figure 2. Prescription Drugs Features
    Figure 3. OTC Drugs Features
    Figure 4. Global Anti-obesity Medicine Market Share by Application: 2020 VS 2027
    Figure 5. Men Case Studies
    Figure 6. Women Case Studies
    Figure 7. Anti-obesity Medicine Report Years Considered
    Figure 8. Global Anti-obesity Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Anti-obesity Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Anti-obesity Medicine Market Share by Regions: 2020 VS 2027
    Figure 11. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
    Figure 12. Global Anti-obesity Medicine Market Share by Players in 2020
    Figure 13. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Anti-obesity Medicine Revenue in 2020
    Figure 15. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
    Figure 16. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027)
    Figure 17. North America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Anti-obesity Medicine Market Share by Type (2016-2027)
    Figure 19. North America Anti-obesity Medicine Market Share by Application (2016-2027)
    Figure 20. North America Anti-obesity Medicine Market Share by Country (2016-2027)
    Figure 21. United States Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Anti-obesity Medicine Market Share by Type (2016-2027)
    Figure 25. Europe Anti-obesity Medicine Market Share by Application (2016-2027)
    Figure 26. Europe Anti-obesity Medicine Market Share by Country (2016-2027)
    Figure 27. Germany Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Anti-obesity Medicine Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Anti-obesity Medicine Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Anti-obesity Medicine Market Share by Region (2016-2027)
    Figure 37. China Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Anti-obesity Medicine Market Share by Type (2016-2027)
    Figure 45. Latin America Anti-obesity Medicine Market Share by Application (2016-2027)
    Figure 46. Latin America Anti-obesity Medicine Market Share by Country (2016-2027)
    Figure 47. Mexico Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Anti-obesity Medicine Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Anti-obesity Medicine Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Anti-obesity Medicine Market Share by Country (2016-2027)
    Figure 53. Turkey Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Alizyme Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 57. Amylin Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 58. Arena Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 59. Boehringer Ingelheim Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 60. Eisai Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 62. Orexigen Therapeutics Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 63. Vivus Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 64. Pfizer Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 65. Roche Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 66. Merck Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 67. Novo Nordisk Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alizyme
Amylin Pharmaceuticals
Arena Pharmaceuticals
Boehringer Ingelheim
Eisai
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Pfizer
Roche
Merck
Novo Nordisk
Frequently Asked Questions
Anti-obesity Medicine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-obesity Medicine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-obesity Medicine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Metal Surgical Clip

Metal Surgical Clip market is segmented by region (country), players, by Type, and by Application ... Read More